×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Intersect ENT, Inc. (NASDAQ:XENT) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year
Yahoo Movies Canada
A week ago, Intersect ENT, Inc. (NASDAQ:XENT) came out with a strong set of third-quarter numbers that could...
2 days ago
Medtronic Brings Intersect ENT Acquisition to a Close
Medical Device and Diagnostic industry
Medtronic Brings Intersect ENT Acquisition to a Close. To satisfy FTC concerns, the Dublin-based company divested Intersect ENT's Fiagon business. ... Medtronic...
5 months ago
Medtronic to Acquire Intersect ENT
PR Newswire
Medtronic's acquisition of Intersect ENT expands the company's portfolio of products used during ear, nose, and throat procedures. The...
32 months ago
Earnhardt to Leave CEO Position at Intersect ENT
Medical Device and Diagnostic industry
Gallahue served as Chairman and CEO at CareFusion from 2011 until March 2015, and prior to that, he was president, CEO and a director of ResMed. He will helm...
5 months ago
Medtronic completes Intersect ENT acquisition
MassDevice
Medtronic (NYSE:MDT) announced that it completed its previously announced $1.1 billion acquisition of Intersect ENT (Nasdaq:XENT).
23 months ago
Medtronic makes FTC-mandated sale to close Intersect ENT deal and scores FDA nod to boot
Fierce Biotech
Medtronic makes FTC-mandated sale to close Intersect ENT deal and scores FDA nod to boot ... It may have taken an order from the Federal Trade...
23 months ago
Medtronic Completes Acquisition of Intersect ENT to Add Innovative Sinus Implants to ENT Portfolio
Hospimedica.com
Medtronic has acquired Intersect ENT's PROPEL and SINUVA (mometasone furoate) sinus implant product lines and technology, intellectual property.
23 months ago
Medtronic completes acquisition of Intersect ENT
PR Newswire
PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it has completed the acquisition of...
23 months ago
Why Medtronic decided to move now on its $1.1B Intersect ENT deal
MedCity News
Why Medtronic decided to move now on its $1.1B Intersect ENT deal. Investors had long expected Intersect ENT to be an acquisition target before...
32 months ago
Intersect ENT wins CE mark for Propel Contour sinus implant
Drug Delivery Business
Intersect ENT (NSDQ:XENT) announced today that it received CE mark approval for its Propel Contour sinus implant.
35 months ago